Anthropic acquires startup company CoefficientBio for approximately $400 million.

According to sources, Anthropic has acquired the artificial intelligence biotechnology startup CoefficientBio for approximately $400 million. The source stated that the team of this startup will join Anthropic's medical health and life sciences department, which is focused on developing tools for various biotechnology processes from drug research and development to clinical commercialization. CoefficientBio was founded in the fall of last year and was developing a platform that allows artificial intelligence to perform tasks related to biotechnology, such as planning drug research and development, managing clinical regulatory strategies, and exploring new drug development opportunities. The company's co-founders include CEO Aris Xylogeorgis and CTO Nathan Frey.